Synairgen Share Price | |
---|---|
Price | 4.36 |
Bid | 4.36 |
Ask | 4.99 |
Change | 0.00 (0.00%) |
Volume | 235,598 |
Open | 4.36 |
High | 4.36 |
Low | 4.36 |
Prev. Close | 4.675 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 201.37m |
Market Capitalisation | £8.78m |
Market Size | 30,000 |
52 Week High | 10.62 |
52 Week High Date | 29-Nov-2023 |
52 Week Low | 3.65 |
52 Week Low Date | 28-Jun-2024 |
# Trades | 20 |
---|---|
Vol. Sold | 59,753 |
Sold Value | £2.61k |
Vol. Bought | 175,845 |
Bought Value | £8.39k |
PE Ratio | -1.043062 |
Earnings | -4.18 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
02-Jul-24 | 16:17:55 | 4.3726 | 10,000 | Sell* | 4.36 | 4.99 | 437.26 | O Ordinary |
02-Jul-24 | 16:16:10 | 4.738 | 9,554 | Buy* | 4.36 | 4.99 | 452.67 | O Ordinary |
02-Jul-24 | 15:26:41 | 4.738 | 5,000 | Buy* | 4.36 | 4.99 | 236.90 | O Ordinary |
02-Jul-24 | 15:09:58 | 4.745 | 2,107 | Buy* | 4.36 | 4.99 | 99.98 | O Ordinary |
02-Jul-24 | 15:09:08 | 4.745 | 13,698 | Buy* | 4.36 | 4.99 | 649.97 | O Ordinary |
02-Jul-24 | 15:06:28 | 4.3726 | 1,681 | Sell* | 4.36 | 4.99 | 73.50 | O Ordinary |
02-Jul-24 | 14:07:01 | 4.7632 | 100,000 | Buy* | 4.36 | 4.99 | 4,763 | O Ordinary |
02-Jul-24 | 12:52:27 | 4.79 | 10 | Buy* | 4.36 | 4.99 | 0.48 | O Ordinary |
02-Jul-24 | 10:44:57 | 4.79 | 104 | Buy* | 4.36 | 4.99 | 4.98 | O Ordinary |
02-Jul-24 | 09:04:00 | 4.3726 | 2,172 | Sell* | 4.36 | 4.99 | 94.97 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
28-Jan-22 | 27-Jan-22 | Buy | Bruce Campbell held the position of Non-Executive Director at the time of this trade.Bruce Campbell | 189.74 | GBX | 7,899 | 8,520 |
28-Jan-22 | 27-Jan-22 | Buy | Bruce Campbell held the position of Non-Executive Director at the time of this trade.Bruce Campbell | 189.42 | GBX | 621 | 8,520 |
12-Aug-21 | 12-Aug-21 | Sell | John C Ward held the position of Finance Director at the time of this trade.John C Ward | 140.00 | GBX | 269,963 | 734,092 |
12-Aug-21 | 12-Aug-21 | Exercise of Option | John C Ward held the position of Finance Director at the time of this trade.John C Ward | 1.00 | GBX | 489,148 | 734,092 |
12-Aug-21 | 12-Aug-21 | Sell | Phillip David Monk held the position of Chief Scientific Officer at the time of this trade.Phillip David Monk | 140.00 | GBX | 220,878 | 423,934 |
Synairgen is a drug discovery and development company founded to combat severe respiratory diseases. Discover SNG001, our breakthrough treatment for COVID-19.